Home — MRC Weatherall Institute of Molecular Medicine

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The MRC WIMM Green Impact team with the Gold Green Impact award.

MRC WIMM achieves Gold Green Impact award

Congratulations to the Institute's Green Impact team, who achieved Gold in the University of Oxford's 2026 Green Impact awards.

Read more

Banner image featuring the words a leader in translating research from bench to clinic, next to an image of a scientist pipetting a pink liquid.

Translating Our Research

Leading research with the aim of improving human health. World-leading research from scientists at the MRC WIMM has been developed into commercial ventures to translate our discoveries into clinics and benefit patients.

Read more

The image depicts CAR T cells killing malignant bone marrow cells that are expressing mutant CALR, illustrated as a red ‘flag’ on the cell surface.

© DrawImpacts

New personalised therapy targets chronic blood cancer

A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving healthy blood cells unharmed, according to a new study led by UCL and University of Oxford researchers.

Read more

Research at the MRC WIMM spans 5 core areas.

© Canva, Science Photo Library

MRC WIMM Research Areas

Research at the MRC WIMM spans 5 core areas.

Read more

Attendees at WIMM Day in the lecture theatre

WIMM Day 2026: connecting people, ideas and scientific discovery

On Tuesday 23rd June, the MRC WIMM community came together at Saïd Business School for the Institute's annual away day, sharing research, professional achievements and much more.

Read more

The MRC WIMM's core mission is to improve human health through the pursuit of fundamental research, the development of new technology, and the translation of discoveries to the clinic.

Discover. Translate. Advance.

The MRC WIMM's core mission is to improve human health through the pursuit of fundamental research, the development of new technology, and the translation of discoveries to the clinic.

Read more

MRC Translational Immune Discovery Unit

Pioneering the future in the study of human immunity to uncover the molecular pathways driving immune-mediated diseases.

Find out more

MRC Molecular Haematology Unit

Understanding how mature blood cells are normally made from stem cells and how this is perturbed in common blood disorders.

Find out more

Centre for Computational Biology

Using computational biology to help understand complex biological systems and combat a range of human diseases.

Find out more

Latest publications

CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis.

Rampotas A. et al, (2026), Sci Transl Med, 18

TiO2 Alternative Coatings for Ferric Pyrophosphate Premixes: Stability and Bioaccessibility Relative to Ferrous Fumarate

Teichman DL. et al, (2026), Innovative Food Science and Emerging Technologies, 111

ChatMDV: Reducing Technical Barriers in Bioinformatics Analysis using Large Language Models.

Kiourlappou M. et al, (2026), Gigascience

Development of a recombinant single-cycle influenza viral vector as an intranasal vaccine against SARS-CoV-2.

Munro J. et al, (2026), Sci Rep

Positive allosteric modulator selective for adult muscle nicotinic acetylcholine receptor.

Webster RG. et al, (2026), Proc Natl Acad Sci U S A, 123

More Publications

Upcoming Seminars

Barrier tissue immunity to pathogenic and commensal fungi

Monday, 06 July 2026, 12pm to 1pm

Speaker(s): Dr Eric Van Dang

Series: TIDU seminars

Antigen specificity of clonally enriched CD8+ T cells in multiple sclerosis

Monday, 06 July 2026, 3pm to 4pm

Speaker(s): Dr Joseph Sabatino (University of California San Francisco)

Series: Unravelling T Cell Recognition: Insights from Immunology and AI

Deciphering the gene regulation of oxygen homeostasis and human fitness through the lens of erythropoietin producing Norn cells

Tuesday, 07 July 2026, 2.30pm to 3.30pm

Speaker(s): Bjørt Katrinardóttir Kragesteen (Karolinska Institutet)

Series: Molecular Haematology Unit, WIMM

Status: Cancelled

TBC

Tuesday, 01 September 2026, 1pm to 2pm

Speaker(s): Akhihiko Yokoyama

Series: Molecular Haematology Unit

More Seminars

MRC WIMM Interactive Timeline

Accessible Version of Timeline